• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coexistence of Standard Modifiable, Other Classical, and Novel and Classical Atherosclerotic Cardiovascular Disease Risk Factors in Middle Eastern Young Women.中东年轻女性中标准可调节、其他经典和新型与经典动脉粥样硬化性心血管疾病危险因素的共存。
Vasc Health Risk Manag. 2024 Jul 8;20:313-322. doi: 10.2147/VHRM.S468209. eCollection 2024.
2
Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study.中东年轻女性的动脉粥样硬化性心血管疾病新的和传统风险因素。ANCORS-YW 研究。
Glob Heart. 2024 Jul 15;19(1):59. doi: 10.5334/gh.1341. eCollection 2024.
3
Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.瑞士住院的年轻急性冠状动脉综合征患者中可改变的心血管危险因素患病率的20年趋势。
Eur J Prev Cardiol. 2023 Oct 10;30(14):1504-1512. doi: 10.1093/eurjpc/zwad077.
4
Modifiable Risk Factors in Young Adults With First Myocardial Infarction.青年首发心肌梗死患者的可调节危险因素。
J Am Coll Cardiol. 2019 Feb 12;73(5):573-584. doi: 10.1016/j.jacc.2018.10.084.
5
Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States.美国动脉粥样硬化性心血管疾病成人的食物不安全范围和社会决定因素。
J Am Heart Assoc. 2021 Aug 17;10(16):e020028. doi: 10.1161/JAHA.120.020028. Epub 2021 Aug 13.
6
Variations in the Prevalence of Risk Factors for Coronary Artery Disease in Rio Grande do Sul-Brazil: A Comparative Analysis between 2002 and 2014.巴西南里奥格兰德州冠状动脉疾病危险因素患病率的变化:2002年与2014年的比较分析
Arq Bras Cardiol. 2015 Dec;105(6):573-9. doi: 10.5935/abc.20150127. Epub 2015 Oct 27.
7
Poor cardiovascular health status among Chinese women.中国女性心血管健康状况不佳。
BMC Cardiovasc Disord. 2020 Nov 25;20(1):497. doi: 10.1186/s12872-020-01748-y.
8
Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.阿利西尤单抗治疗 2 型糖尿病合并动脉粥样硬化性心血管疾病患者:ODYSSEY DM-DYSLIPIDEMIA 和 DM-INSULIN 研究分析。
Cardiovasc Diabetol. 2019 Nov 9;18(1):149. doi: 10.1186/s12933-019-0951-9.
9
High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.高敏 C 反应蛋白与致动脉粥样硬化脂质指标不相符与一级预防中动脉粥样硬化性心血管疾病的发生:ARIC 研究。
J Am Heart Assoc. 2020 Feb 4;9(3):e013600. doi: 10.1161/JAHA.119.013600. Epub 2020 Jan 30.
10
Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999-2018.1999-2018 年美国与动脉粥样硬化性心血管疾病相关的多种疾病的流行病学。
BMC Public Health. 2024 Jan 23;24(1):267. doi: 10.1186/s12889-023-17619-y.

本文引用的文献

1
[A review on cardiovascular disease risk prediction models in the elderly].[老年人心血管疾病风险预测模型综述]
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Jun 10;44(6):1013-1020. doi: 10.3760/cma.j.cn112338-20221104-00940.
2
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.动脉粥样硬化与炎症:通论病理过程学说的启示。
Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910.
3
Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association.女性心血管疾病风险因素:种族和民族的影响:美国心脏协会的科学声明。
Circulation. 2023 May 9;147(19):1471-1487. doi: 10.1161/CIR.0000000000001139. Epub 2023 Apr 10.
4
Locking the Revolving Door: Racial Disparities in Cardiovascular Disease.锁定旋转门:心血管疾病中的种族差异。
J Am Heart Assoc. 2023 Apr 18;12(8):e025271. doi: 10.1161/JAHA.122.025271. Epub 2023 Mar 21.
5
Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease.家族史中的可修正风险因素与未来心血管疾病的关联。
J Am Heart Assoc. 2023 Mar 21;12(6):e027881. doi: 10.1161/JAHA.122.027881. Epub 2023 Mar 9.
6
Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.开发和验证一种适用于阿联酋国民的新型 10 年心血管风险预测列线图。
BMJ Open. 2022 Dec 29;12(12):e064502. doi: 10.1136/bmjopen-2022-064502.
7
Cardiovascular disease risk in offspring of polycystic ovary syndrome.多囊卵巢综合征患者后代的心血管疾病风险。
Front Endocrinol (Lausanne). 2022 Nov 30;13:977819. doi: 10.3389/fendo.2022.977819. eCollection 2022.
8
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?易损动脉粥样硬化斑块:是否存在分子特征?
Int J Mol Sci. 2022 Nov 7;23(21):13638. doi: 10.3390/ijms232113638.
9
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.动脉粥样硬化性心血管疾病风险评估:美国预防心脏病学会临床实践声明
Am J Prev Cardiol. 2022 Mar 15;10:100335. doi: 10.1016/j.ajpc.2022.100335. eCollection 2022 Jun.
10
Pathophysiology of Atherosclerosis.动脉粥样硬化的病理生理学。
Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346.

中东年轻女性中标准可调节、其他经典和新型与经典动脉粥样硬化性心血管疾病危险因素的共存。

Coexistence of Standard Modifiable, Other Classical, and Novel and Classical Atherosclerotic Cardiovascular Disease Risk Factors in Middle Eastern Young Women.

机构信息

Department of Internal and Family Medicine, Faculty of Medicine The Hashemite University, Zarqa, Jordan.

Department of Cardiology, Istishari Hospital, Amman, Jordan.

出版信息

Vasc Health Risk Manag. 2024 Jul 8;20:313-322. doi: 10.2147/VHRM.S468209. eCollection 2024.

DOI:10.2147/VHRM.S468209
PMID:39005236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11244616/
Abstract

BACKGROUND

The coexistence of multiple standard modifiable risk factors (SMuRFs),classical and novel risk factors (RFs) for atherosclerotic cardiovascular disease (ASCVD) is common in the Middle East (ME). There is a paucity of data on the coexistence of these RFs in ME young women.

AIM

Comparing the prevalence and the statistical patterns of the SMuRFs, classical and novel RFs in target population.

METHODS

In this case-control (1:2) study, consecutive young women aged 18-50 years were enrolled in 12 centers (July 2021 to October 2023). Prevalence and coexistence of 19 RFs were compared between cases with ASCVD and their controls. The RFs included SMuRFs (hypertension, type 2 diabetes, dyslipidemia, and cigarette smoking), other classical RF (obesity, family history of premature ASCVD, and physical inactivity), novel RFs and social determinants of health (health insurance, place of residence, depression, and level of education).

RESULTS

The study included 627 subjects; 209 had ASCVD (median age 46 years, IQR 49-42 years) and 418 controls (median age 45 years, IQR 48-41 years). The presence of 1-2 RFs; (ASCVD: 63.2%, Control: 54.1%, p=0.037) and 3-4 RFs; (ASCVD: 27.8%, Control: 3.3%, p < 0.001) SMuRFs was more prevalent in women with ASCVD. Similarly, the presence of 4-5 RFs; (ASCVD: 40.7%, Control: 14.6%, p<0.001), and 6-7 (ASCVD: 10.5%, Control: 1%, p < 0.001). The classical RF were also significantly common in these women. The distribution of multiple novel RF was not statistically significant across both groups. Finally, regarding the socioeconomic RFs in women with ASCVDs, the presence of 1-2 RFs (ASCVD: 59.8%, Control: 76.1%, p < 0.001) was significantly less common while the presence of 3-4 RFs (ASCVD: 39.2%, Control: 21.8%, p < 0.001) was vastly more common.

CONCLUSION

An elevated rate of coexistence of classical RF in the case group, mainly socioeconomic and SMuRFs. By managing them primary and secondary ASCVDs prevention attained.

摘要

背景

在中东(ME),多种标准可改变的风险因素(SMuRFs)、经典和新型风险因素(RFs)同时存在于动脉粥样硬化性心血管疾病(ASCVD)患者中较为常见。然而,关于这些 RFs 在 ME 年轻女性中的共存情况,数据仍然较为匮乏。

目的

比较目标人群中 SMuRFs、经典和新型 RFs 的患病率和统计学模式。

方法

本病例对照(1:2)研究纳入了 12 个中心连续就诊的年龄在 18-50 岁之间的年轻女性(2021 年 7 月至 2023 年 10 月)。比较 ASCVD 患者与其对照组中 19 种 RFs 的患病率和共存情况。RFs 包括 SMuRFs(高血压、2 型糖尿病、血脂异常和吸烟)、其他经典 RF(肥胖、早发 ASCVD 家族史和体力活动不足)、新型 RF 和社会决定因素(健康保险、居住地、抑郁和教育水平)。

结果

该研究共纳入 627 名受试者;209 名患有 ASCVD(中位年龄 46 岁,IQR 49-42 岁),418 名对照组(中位年龄 45 岁,IQR 48-41 岁)。患有 ASCVD 的女性中存在 1-2 种 RFs(63.2%,对照组为 54.1%,p=0.037)和 3-4 种 RFs(27.8%,对照组为 3.3%,p<0.001)的情况更为常见。同样,存在 4-5 种 RFs(40.7%,对照组为 14.6%,p<0.001)和 6-7 种 RFs(10.5%,对照组为 1%,p<0.001)的情况在这些女性中也更为常见。这些女性中经典 RF 的分布也显著更为常见。两组中多个新型 RF 的分布没有统计学意义。最后,在 ASCVD 女性中,社会经济 RFs 的存在情况也有所不同。患有 ASCVD 的女性中存在 1-2 种 RFs(59.8%,对照组为 76.1%,p<0.001)的情况显著较少,而存在 3-4 种 RFs(39.2%,对照组为 21.8%,p<0.001)的情况则更为常见。

结论

病例组中经典 RF 的共存率较高,主要为社会经济和 SMuRFs。通过对这些因素进行一级和二级 ASCVD 预防,可以实现 ASCVD 的预防。